tiprankstipranks
TherapeuticsMD (TXMD)
NASDAQ:TXMD
US Market

TherapeuticsMD (TXMD) Income Statement

Compare
2,238 Followers

TherapeuticsMD Income Statement

Last quarter (Q3 2024), TherapeuticsMD's total revenue was $547.00K, a decrease of -1132.08% from the same quarter last year. In Q3, TherapeuticsMD's net income was $-609.00K. See TherapeuticsMD’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.30M$ 69.96M$ 86.95M$ 64.87M$ 49.65M
Gross Profit
$ 1.30M$ 68.57M$ 68.11M$ 48.90M$ 43.31M
Operating Expenses
$ 9.82M$ 57.90M$ 207.88M$ 204.44M$ 194.52M
Depreciation and Amortization
$ 122.00K$ 1.19M$ 736.00K$ 5.47M$ 2.45M
EBITDA
$ -8.40M$ 11.86M$ -78.57M$ -149.47M$ -156.31M
Operating Income
$ -8.52M$ 20.14M$ -139.77M$ -155.54M$ -151.21M
Other Income/Expenses
$ 781.00K$ -117.00K$ 272.00K$ -27.98M$ -24.94M
Pretax Income
$ -7.74M$ 1.07M$ -172.41M$ -183.52M$ -176.14M
Net Income
$ -10.28M$ 112.00M$ -205.60M$ -212.70M$ -196.03M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.55$ -10.35$ -25.83$ -38.58$ -39.79
Diluted EPS
$ -0.74$ -10.35$ -25.83$ -38.58$ -39.79
Weighted Average Shares Outstanding
13.89M 9.03M 7.96M 5.51M 4.93M
Weighted Average Shares Outstanding (Diluted)
10.44M 9.03M 7.96M 5.51M 4.93M
Currency in USD

TherapeuticsMD Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis